ALHC Logo

Alignment Healthcare, Inc. (ALHC) 

NASDAQ
Market Cap
$2.33B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
141 of 774
Rank in Industry
5 of 9

Largest Insider Buys in Sector

ALHC Stock Price History Chart

ALHC Stock Performance

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage …

Insider Activity of Alignment Healthcare, Inc.

Over the last 12 months, insiders at Alignment Healthcare, Inc. have bought $496,779 and sold $15.01M worth of Alignment Healthcare, Inc. stock.

On average, over the past 5 years, insiders at Alignment Healthcare, Inc. have bought $579,195 and sold $272.43M worth of stock each year.

Highest buying activity among insiders over the last 12 months: KAO JOHN E (Chief Executive Officer) — $496,779.

The last purchase of 103,000 shares for transaction amount of $496,779 was made by KAO JOHN E (Chief Executive Officer) on 2024‑03‑14.

List of Insider Buy and Sell Transactions, Alignment Healthcare, Inc.

2024-11-15SalePresident, Markets
30,000
0.0139%
$11.35$340,560+4.00%
2024-11-11SaleChief Executive Officer
90,000
0.0473%
$13.42$1.21M-8.14%
2024-11-11Saledirector
6,920
0.0037%
$13.73$95,012-8.14%
2024-11-11SaleChief Financial Officer
30,500
0.016%
$13.42$409,356-8.14%
2024-11-04SaleChief Experience Officer
20,500
0.0105%
$13.06$267,699+0.15%
2024-11-01SaleChief Experience Officer
4,500
0.0024%
$12.98$58,413+2.63%
2024-10-31SaleChief Financial Officer
36,197
0.0184%
$12.04$435,982+6.65%
2024-10-29SaleChief Financial Officer
4,483
0.0024%
$12.01$53,856+11.49%
2024-10-15SalePresident, Markets
30,000
0.0152%
$10.77$323,082+14.18%
2024-10-14SaleChief Financial Officer
30,500
0.0165%
$11.50$350,872+6.89%
2024-10-09SaleChief Executive Officer
90,000
0.0479%
$11.33$1.02M+4.15%
2024-10-08SaleChief Medical Officer
22,460
0.0116%
$11.03$247,734+0.38%
2024-10-08SaleChief Financial Officer
39,320
0.0223%
$12.04$473,350+0.38%
2024-10-02SaleChief Financial Officer
9,125
0.0047%
$11.01$100,432+3.95%
2024-10-01SaleChief Legal and Admin. Officer
667
0.0004%
$11.79$7,866+17.10%
2024-10-01SaleChief Financial Officer
21,375
0.0107%
$10.66$227,824+17.10%
2024-09-17Saledirector
16,413
0.0086%
$11.77$193,181-1.88%
2024-09-16SaleChief Executive Officer
90,000
0.0478%
$11.70$1.05M-0.35%
2024-09-16SalePresident, Markets
30,000
0.0159%
$11.70$351,027-0.35%
2024-09-13Saledirector
25,000
0.0132%
$12.00$300,013-3.45%

Insider Historical Profitability

0.65%
KAO JOHN EChief Executive Officer
2453100
1.2797%
$12.15121
KONOWIECKI JOSEPH Sdirector
1134888
0.592%
$12.1518+0.65%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
General Atlantic$302.53M31.960.99M0%+$07.86
Warburg Pincus$88.9M9.3717.92M0%+$04.91
Fidelity Investments$84.27M8.8916.99M-0.07%-$55,224.640.01
The Vanguard Group$45.83M4.839.24M+1.02%+$462,579.53<0.01
T Rowe Price Investment Management Inc$41.19M4.348.3M-31.23%-$18.71M0.03
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.